Changes of antimicrobial resistance and extended-spectrum β-lactamase production in Klebsiella spp. strains

Journal of Infection and Chemotherapy

Volumn 10, Issue 4, 2004, Pages 212-215

  Timko, Jaroslav ^a  

^a Central Military Hospital   (Slovakia)

Author keywords

Antimicrobial resistance; ESBL; Klebsiella pneumoniae

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; MEROPENEM; PIPERACILLIN; SULBACTAM; SULFONAMIDE; SULTAMICILLIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DRUG EFFICACY; ENZYME SYNTHESIS; GRAM NEGATIVE BACTERIUM; HOSPITAL DEPARTMENT; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE; KLEBSIELLA; MULTIDRUG RESISTANCE; NONHUMAN; PUBLIC HOSPITAL; SLOVAKIA;

EID: 4644329459     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-004-0326-2     Document Type: Article

References (26)

1. Bush K, Jacoby GA, Medeiros AA. Afunctional classification scheme for β-lactamases and its correlation with molecular structures. Antimicrob Agents Chemother 1995;39:1211-33.
2. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557-84.
3. Livermore DM. β-Lactamase-mediated resistance and opportunities for its control. J Antimicrob Chemother 1998;41(Suppl D):25-41.
4. Tzelepi E, Panagiota G, Sofianou D, Loukova V, Kemerglou A, Tsakris A. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol 2000;38:542-6.
5. Rahal JJ. Extended-spectrum β-lactamases: how big is the problem? Clin Microbiol Infect 2000;6(Suppl 2):2-6.
6. Bonnet R, Sampaio JLM, Labia R, De Champs C, Sirot D, Chanal C, et al. A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob Agents Chemother 2000;44:1936-42.
7. Babini G, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. from intensive care units in southern and western Europe in 1997-1998. J Antimicrob Chemother 2000;45:183-9.
8. Kaye KS, Fraimow HS, Abrutyn E. Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin N Am 2000;14:293-319.
9. Garcia-Rodriguez JA, Jones RN. MYSTIC Programme Study Group. Antimicrobial resistance in gram-negative isolates from European intensive care units: data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme. J Chemother 2002;14(1):25-32.
10. Turner PJ. MYSTIC (Meropenem yearly susceptibility test information collection): a global overview. J Antimicrob Chemother 2000;42:9-23 (Topic T2).
11. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the SENTRY Antimicrobial Resistance Surveillance Program, 1997-99. Clin Infect Dis 2001;32(Suppl 2):81-93.
12. Pfaller MA, Jones RN, Doern GV, Kugler K, The SENTRY participants group. Bacterial pathogens isolated from patients with bloodstream infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada 1997). Antimicrob Agents Chemother 1998;42:1762-70.
13. Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates of S. pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 1998;27:764-70.
14. Livermore DM, Yuan M. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996;38:409-24.
15. Gattringer R, Niks M, Ostertag R, Schwarz K, Medvedovic H, Graninger W, et al. Evaluation of MIDITECH automated colorimetric MIC reading for antimicrobial susceptibility testing. J Antimicrob Chemother 2002;49(4):651-9.
16. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10(4):867-78.
17. Mainardi JL, Carlet J, Acar J. Antibiotic resistance problems in the critical care unit. Crit Care Clin 1998;14:199-219.
18. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998;11(4):589-603.
19. Jones RN. Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: afive-year summary from the SENTRY antimicrobial surveillance program (1997-2001). Semin Respir Crit Care Med 2003;24(1):121-34.
20. Koláž M, Látal T, Čermák P. Klinicko-mikrobiologické podklady racionální antibiotické léčby. Prague: Trios; 2002. p. 98-100.
21. Wise R, Andrews JM. Local surveillance of antimicrobial resistance. Lancet 1998;352:657-8.
22. Paterson DL, Ko W, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001;39(6):2206-12.
23. Goossens H. The problem of ESBL producers - a worldwide survey into physician awareness and perception. Program and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy September 27-30, 2002, San Diego, CA.
24. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001;15;32(suppl 2):S94-103.
25. Pena C, Pujol M, Ardanuy C, Ricart A, Pallares R, Linares J, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae isolates producing extended-spectrum betalactamases. Antimicrob Agents Chemother 1998;42:53-8.
26. Gruson D, Hilbert G, Vargas F, et al. Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Respir Crit Care Med 2000;162:837-43.